¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"extracellular fluid volume"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • volume dilatometer
    ºÎÇÇÆØÃ¢°è, ¿ëÀûÆØÃ¢°è
  • volume elasticity coefficient
    ¿ëÀûź·Â·ü
  • volume expander
    Ç÷·®Áõ·®Á¦
  • volume fraction
    ºÎÇǺÐÀ², ¿ëÀûºÐÀ²
  • volume gradient echo technique
    ¿ëÀû±â¿ï±â¿¡ÄÚ±â¹ý
  • volume index
    ºÎÇÇÁö¼ö
  • volume of distribution
    ºÐÆ÷¿ëÀû
  • volume overload
    ¿ëÀû°úºÎÇÏ
  • volume pulse
    ¿ëÀû¸Æ¹Ú
  • volume receptor
    ¿ëÀû¼ö¿ë±â
  • volume-cycled ventilator
    ¿ëÀûÁÖ±âÇüȯ±â±â
  • aqueous fluid
    ¹æ¼ö
  • ascitic fluid
    º¹¼ö
  • air fluid level
    °ø±â¾×üÃþ
  • allantoic fluid
    ¿ä¸·°ø°£¾×, ¿ä¸·°­¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • free pleural fluid
    ÀÚÀ¯°¡½¿¸·»ïÃâ¾×
  • gastric replacement fluid
    À§´ëÄ¡¾×, À§º¸¾×
  • hydatid fluid
    Æ÷Ãæ¾×
  • hyperosmotic fluid
    °í»ïÅõ¾×
  • hypertonic fluid
    °íÀå¾×
  • hypoosmotic fluid
    Àú»ïÅõ¾×
  • hypotonic fluid
    ÀúÀå¾×
  • intersitital fluid
    »çÀÌÁú¾×, °£Áú¾×
  • intestinal replacement fluid
    âÀÚ´ëÄ¡¾×, À庸¾×
  • intracellular fluid
    ¼¼Æ÷³»¾×
  • intraluminal fluid
    °ü³»¾×, °­³»¾×, °ø°£³»¾×
  • pericardial fluid
    ½ÉÀ帷¾×
  • pleural effusion fluid
    °¡½¿¸·»ïÃâ¾×, Èä¼ö
  • seminal fluid
    (¢¡semen) Á¤¾×
  • serous fluid
    Àå¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • CSF=£¾cerebrospinal fluid
    ³úô¼ö¾×.
  • Champys fixing fluid
    ¼§ÇǰíÁ¤¾×.
  • FLAIR(fluid attenuated inversion recovery)
    ¾×ü °¨¾à ¹ÝÀü ȸº¹
  • Fluid compartments
    ü¾×±¸¿ª(ô÷äûÏ¡æ´)
  • Fluid volumes, body, measurement of 1-2
    ü¾×(ô÷äû)ºÎÇÇ, ÃøÁ¤(ö´ïï)
  • Hyperosmotic fluid
    °í»ïÅõ¼º¿ë¾×(ÍÔß¶÷âàõéÁäû)
  • Hypertonic fluid
    °íÀ强¿ë¾×(ÍÔíåàõéÁäû)
  • Hypo-osmotic fluid
    Àú»ïÅõ¿ë¾×(î¸ß¶÷âéÁäû)
  • Hypotonic fluid
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû)
  • ISF= interstitial fluid
    °£Áú¾×(Êàòõäû).
  • ISF=£¾interstitial fluid
    °£Áú¾×.
  • Interstitial fluid
    °£Áú¾×(Êàòõäû)
  • Interstitial fluid pressure
    °£Áú¾×¾Ð·Â(ÊàòõäûäâÕô)
  • Intraocular fluid
    ¾È±¸³»¾×(äÑϹҮäû)
  • air fluid level
    °ø±â ¾×üÃþ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bleaching fluid
    Ç¥¹é¾×(ø÷ÛÜäû).
  • blood cerebrospinal fluid barrier
    Ç÷³úô¼ö¾×À庮, Ç÷¾×³úô¼ö¾×°ü¹®
  • blood cerebrospinal fluid barrier
    Ç÷³úô¼ö¾×À庮, Ç÷¾×³úô¼ö¾×°ü¹®.
  • blood-brain/cerebrospinal fluid barrier
    Ç÷-³ú/³úô¼ö¾× À庮.
  • body fluid
    ü¾×
  • body fluid
    ü¾×(ô÷äû)
  • body fluid compartment
    ü¾×ºÐȹ, ü¾× ±¸ºÐ
  • cerebrospinal fluid
    ³úô¼ö¾×
  • cerebrospinal fluid
    ³úô¼ö¾×(Òàô±âÐäû).
  • cerebrospinal fluid
    ³úô¼ö¾×
  • cerebrospinal fluid =CSF
    ³úô¼ö¾×(¡­äû)
  • cerebrospinal fluid =CSF
    ³úô¼ö¾×(¡­äû).
  • cerebrospinal fluid flow void sign
    ³úô¼ö¾× È帧 ¼Ò½Ç ¡ÈÄ
  • cerebrospinal fluid otorrhea =otorrhea cerebrospi
    ³úô¼ö¾×ÀÌ·ç
  • cerebrospinal fluid otorrhea<³ª> otorrhea cerebrospinalis
    (³úô)¼ö¾× ÀÌ·ç(¡­äûì¼×©).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • volume
    ºÎÇÇ, ¿ëÀû, ¡ìÃ¥ÀÇ¡í±Ç
  • volume acquisition
    ¿ëÀûȹµæ
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
  • volume coil
    ¿ëÀûÄÚÀÏ
  • volume element = voxel
    È­Àû¼Ò
  • volume gradient echo technique
    ¿ëÀû°æ»ç¿¡ÄÚ±â¹ý
  • volume magnetic susceptibility
    ¿ëÀûÀÚÈ­À²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IFV interstitial fluid volume; intracellular fluid volume
ECV epithelial cell vacuolization; extracellular volume; extracorporeal volume
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
BECF blood extracellular fluid
ECF effective capillary flow; eosinophilic chemotactic factor; erythroid colony formation; extended care...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AEP Alkaline Extracellular Protease
ECM Cell-extracellular matrix
E Extracellular
EC Extracellular
EF Extracellular Factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • volume conductor
    ÀÔüÀû µµÃ¼
  • volume depletion state
    ¿ë·® °í°¥ »óÅÂ, ü¾× °áÇÌ »óÅÂ
  • volume elasticity
    ¿ëÀû ź¼º
  • volume expander
    Ç÷·® Áõ·®Á¦
  • volume overload
    Ç÷·® °úºÎÇÏ
  • volume receptor
    ¿ëÀû ¼ö¿ë±â
  • volume sensitive respirator
    Á¦·® ÀΰøÈ£Èí±â, ¿ë·® Á¦ÇÑ ÀΰøÈ£Èí±â
  • weight/volume percent
    üÁß/¿ëÀû ·ü
  • amniotic fluid embolism
    ¾ç¼ö »öÀüÁõ
    ºÐ¸¸ ½Ã¿Í ºÐ¸¸ Á÷ÈÄ¿¡ ¹ß»ýÇÏ´Â Áö±ØÈ÷ ÁßÇÑ ÇÕº´ÁõÀ¸·Î½á ÃâÇ÷, µ¶Ç÷Áõ, Æó»öÀüÁõ°ú °°Àº Ä¡¸íÀûÀÎ ÇÕº´Áõ°ú ÇÔ²² »ê¸ð »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ´Ù. 5¸¸¸í Áß 1¸í²Ã·Î ¹ß»ýÇϸç 89%ÀÇ »ç¸Á·üÀ» º¸ÀδÙ.
  • bleaching fluid
    Ç¥¹é ¾×
  • blister fluid
    ¼öÆ÷ ¾×
  • blood cerebrospinal fluid barrier
    Ç÷³ú ô¼ö¾× À庮, Ç÷¾× ³úô¼ö¾× °ü¹®
  • body fluid compartment
    ü¾× ºÐȹ, ü¾× ±¸ºÐ
  • cerebrospinal fluid
    ³ú ô¼ö¾×
    ³ú, ô¼ö¸¦ ¼øÈ¯ÇÏ´Â ¾×ü.
  • cerebrospinal fluid leakage
    ³ú ô¼ö¾× À¯Ãâ
    »ç°ñÀÇ ¹Ì·Î ÆÇÀ» ÅëÇØ ¹èÃâµÇ¸ç 24½Ã°£ ³»Áö 72½Ã°£ À̳»¿¡ ¸ØÃß°Ô µÈ´Ù. Ưº°ÇÑ Ä¡·á¸¦ ÇÏÁö ¾Ê°í Ç×»ýÁ¦¸¦ Åõ¿©ÇÏ¸ç ±â´Ù¸°´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
closing volume The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure.
(12 Dec 1998)
plasma volume Volume of plasma in the circulation. It is usually measured by indicator dilution techniques.
(12 Dec 1998)
pressure-volume index Method of evaluating the cerebrospinal fluid hydrodynamics.
(05 Mar 2000)
specimen interaction volume <microscopy> The volume inside the specimen in which all specimen interactions occur during electron beam irradiation.
(05 Aug 1998)
standard volume The volume of an ideal gas at standard temperature and pressure, approximately 22.414 liters.
(05 Mar 2000)
stroke volume <physiology> The amount of blood pumped out of one ventricle of the heart as the result of a single contraction. A measure of the effectiveness of ventricular contraction.
(16 Dec 1997)
distribution volume The volume throughout which an added tracer substance appears to have been evenly distributed, calculated by dividing the amount of tracer added by its concentration after equilibration.
(05 Mar 2000)
inspiratory reserve volume The extra volume of air that can be inspired with maximal effort after reaching the end of a normal, quiet inspiration. Common abbreviation is irv.
(12 Dec 1998)
interstitial lung disease with increased volume <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM)
(12 Dec 1998)
tidal volume The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are tv or v with subscript t.
(12 Dec 1998)
elution volume <chemistry> The amount of eluant which has passed through the column in column chromatography before a particular peak in an elution profile appears, or before a specific substance of interest comes out with the eluant, separated out of the original mixed substance.
(09 Oct 1997)
end-diastolic volume The amount of blood in the ventricle immediately before a cardiac contraction begins; a measurement of cardiac filling between beats, related to diastolic function.
(05 Mar 2000)
end-systolic volume The amount of blood in the ventricle at the end of the cardiac ejection period and immediately preceding the beginning of ventricular relaxation; a measurement of the adequacy of cardiac emptying, related to systolic function.
(05 Mar 2000)
erythrocyte volume Volume of circulating erythrocytes. It is usually measured by radioisotope dilution technique.
(12 Dec 1998)
expiratory reserve volume The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is erv.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á